Product Information
HYDROMORPHONE 8 MG TABLET is a generic product labeled by SpecGx LLC, priced at $0.5609 per EA under NDC 00406324901. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Dec 23, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
8 mg/1
Manufacturer
SpecGx LLCNDC
00406324901
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYDROMORPHONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076855FDA Approved
12/23/2004
TE Code
AB
On Market Since
12/23/2004
Pharmacological Classes
Price Statistics
The NADAC for HYDROMORPHONE 8 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 27.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5609 per EA |
|---|---|
| All-time high | $0.5683 (Sep 16, 2026) |
| All-time low | $0.2311 (Nov 20, 2019) |
| 52-week high | $0.5683 |
| 52-week low | $0.5470 |
| Median price | $0.3138 |
| Average price | $0.3574 |
| Largest weekly change | +25.0% (Aug 23, 2023) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
SpecGx LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
hydromorphone hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROMORPHONE 8 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HYDROMORPHONE 8 MG TABLET, manufactured by SpecGx LLC, is $0.5609 per EA (NDC 00406324901), effective Sep 30, 2026.
How has the price of HYDROMORPHONE 8 MG TABLET changed over time?
Over the history we have for it, the NADAC for HYDROMORPHONE 8 MG TABLET has risen 27.0%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for HYDROMORPHONE 8 MG TABLET?
Since Nov 28, 2013, the NADAC for HYDROMORPHONE 8 MG TABLET has ranged from a low of $0.2311 (Nov 20, 2019) to a high of $0.5683 (Sep 16, 2026), with a median of $0.3138 per EA.
Are there cheaper alternatives to HYDROMORPHONE 8 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as HYDROMORPHONE 8 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures HYDROMORPHONE 8 MG TABLET?
HYDROMORPHONE 8 MG TABLET (NDC 00406324901) is labeled by SpecGx LLC, and CMS classifies it as a generic product.